Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin duration in complicated urinary tract infections
NCT03160807Phase 4Unknown
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Apr 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levofloxacin in complicated urinary tract infection (cUTI) (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Percentage of patients with clinical cure rates at test of cure visit at 5 days. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT03160807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160807.